Provided by Tiger Trade Technology Pte. Ltd.

Gilead Sciences

144.81
-0.8400-0.58%
Post-market: 143.39-1.4242-0.98%19:57 EDT
Volume:6.02M
Turnover:871.24M
Market Cap:179.66B
PE:-55.38
High:145.91
Open:145.07
Low:143.67
Close:145.65
52wk High:157.29
52wk Low:108.46
Shares:1.24B
Float Shares:1.24B
Volume Ratio:1.15
T/O Rate:0.49%
Dividend:3.22
Dividend Rate:2.22%
EPS(TTM):-2.6150
EPS(LYR):6.78
ROE:-20.68%
ROA:14.09%
PB:15.19
PE(LYR):21.36

Loading ...

Gilead, Merck Weekly HIV Pill Keeps Virus Suppressed in Late-stage Trials

Reuters
·
Jul 22

Gilead Sciences Cut to Market Perform from Outperform by Leerink Partners

Dow Jones
·
Jul 22

Gilead to present new HIV research at AIDS 2026

TIPRANKS
·
Jul 21

Gilead Posts Press Release on Once-weekly Oral HIV Regimen Trial Results

Reuters
·
Jul 21

Leerink Partners Downgrades Gilead Sciences to Market Perform From Outperform, Adjusts PT to $127 From $146

MT Newswires Live
·
Jul 21

GSK Notifies Availability of Viiv Healthcare AIDS 2026 Data Presentation Announcement

Reuters
·
Jul 21

Gilead : Leerink Partners Cuts to Market Perform from Outperform; Cuts Target Price to $127 from $146

THOMSON REUTERS
·
Jul 21

Moderna Inc. Stock Slides 3.8%, Underperforms Peers

Dow Jones
·
Jul 21

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Jul 18

Gilead’s Zamzetoclax Trial Update: What a Terminated Phase 1 Means for GILD Investors

TIPRANKS
·
Jul 18

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-07-17

Reuters
·
Jul 17

Is Gilead Sciences (GILD) Fully Valued Following Mixed Earnings And A Full Year EPS Miss?

Simply Wall St.
·
Jul 17

Gilead Chief Comm & Corp Aff Officer Johanna Mercier Sells 3,000 Shares for $389,757.60

Reuters
·
Jul 17

Moderna Inc. Stock Sheds 7.5%, Underperforms Peers

Dow Jones
·
Jul 17

Movement Alert|Gilead Sciences Rises 3.02% in Regular Trading, Lifted by Broad Biotech Sector Strength

Market Focus
·
Jul 17

Gilead Targets Long-Acting HIV Regimens With New Injectable Study

TIPRANKS
·
Jul 17

Kalshi to Allow Bets on Clinical Trials, FDA Decisions

Reuters
·
Jul 16

Analysts Have Conflicting Sentiments on These Healthcare Companies: Gilead Sciences (GILD) and Johnson & Johnson (JNJ)

TIPRANKS
·
Jul 16

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 16

Gilead Bdrs in Brazil Undergo 6-for-1 Stock Split, Ratio Shifts to 1:12

Reuters
·
Jul 16